ICH E6 (R3) Guideline on good clinical practice (GCP)

International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use

GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5

23 January 2025. Date for coming into effect 23 July 2025

ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.​

The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.

With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.

 

TABLE OF CONTENTS

I. INTRODUCTION 
II. PRINCIPLES OF ICH GCP
III.  ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) 
2.  INVESTIGATOR 
3. SPONSOR 
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY

 

© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.

Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000

Clinical Research News

Efter en type 1-diabetesdiagnose begynder kapløbet mod tiden. Et nyt studie forsøger at bevare kroppens egen insulin
Hvor lavt bør det "dårlige" kolesterol være? Studie tester nyt mål for højrisikopatienter
DYNE-251 testes i et fase 3-forsøg hos patienter med Duchenne Muskeldystrofi
Oral GLP-1 skal testes på personer med type 2-diabetes, der faster under Ramadanen
En simpel, men vigtig forholdsregel: Studie tester smarte advarsler til forebyggelse af svangerskabsforgiftning
Læger vil blive påmindet i tide: Studie tester, om notifikationer forbedrer behandlingen af diabetes og nyresygdom
Studie fra Radiological Society of North America: Genikulær arterieembolisering reducerer smerter ved knæartrose i 12 måneder

Kommende kliniske forsøg

Clinical Research Jobs

More jobs

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

Abonner